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Background: The common inherited disorders of hemoglobin, hemoglobinopathies, course a significant health problem. Due to migration they are now encountered in many countries of the world. This rather new health care problem in the Northern Europe raises the question of development of screening programs.
Objectives: The overall objective of the present health technology assessment was to provide a multifaceted basis for the decision on whether a screening program among pregnant immigrants should be established in Denmark. The aims were to elucidate the following issues: 1) to characterize and evaluate technical aspects of the program 2) to perform a literature- based evaluation of existing evidence for designing a screening program 3) to uncover and describe logistical and ethical issues from the patients’ point of view, 4) to compare different organizational models, and 5) to perform a cost-effectiveness analysis.
Methods: A literature search was performed and a three years pilot screening program (January 2005 – December 2007) was established in a part of Denmark covering about 600,000 inhabitants. Data were systematically collected from the laboratory information systems as well as medical records concerning the pregnant women investigated.
Results: Based on the literature, good evidence exists on how to design screening programs in different population settings, and the technology required is present in the relevant laboratories in Denmark. The prevalence of hemoglobinopathy among pregnant women was 2 %. The health technology assessment revealed several organizational challenges as only one third of the pregnant immigrants were tested. The economical analyses showed that the screening program was cost-effective if two cases of serious hemoglobinopathy could be detected annually.
Conclusion: The present health technology assessment provides a basis for a political decision on whether and how a future screening program should be implemented in Denmark.
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